Objective
For many disabling or fatal diseases, there is pre-clinical or clinical evidence of the potential therapeutic efficacy of gene therapy and, yet, the limitations of current gene transfer technologies have prevented success or even caused serious adverse events leading to termination of trials. PERSIST will explore the use of highly innovative gene-modifying and delivery technologies and capitalize on recent discoveries in gene expression control to develop radical solutions to the problem of precisely controlling the fate and expression of exogenous genetic information in gene therapy with applications in these and other deadly diseases. Our proposal combines 20 of Europe’s outstanding experts from 8 countries in the field of genetic engineering for persisting gene expression. Partners have pioneered the use of Zinc Finger Nucleases, engineered recombinases and transposases for gene targeting, synthetic promoters, epigenetic switches and micro-RNA for regulating gene expression, developed state-of-the-art gene delivery platforms based on lentiviral, AAV and gutless adenoviral vectors, conducted front-line clinical trials, and productively collaborated in previous FP projects. PERSIST includes 16 work packages of which 6 focus on vector innovations (part A: emerging technologies), 6 on applications & evaluation (part B), 1 on process development and the remaining 2 on training/dissemination and project management including IPR issues. Targeting deadly diseases, such as inherited immunodeficiencies, storage disorders and haemophilias, PERSIST is in line with the Strategic Research Agenda (SRA) of the Innovative Medicines Initiative (IMI) and will result in: faster discovery and development of better medicines; more attractive professional environment for scientists; better European expertise and know-how to attract biomedical R&D investment in Europe; and a stronger competitive advantage for SMEs, spin-offs and start-ups to enhance Europe’s economy.
Fields of science
Keywords
Call for proposal
FP7-HEALTH-2007-B
See other projects for this call
Funding Scheme
CP-IP - Large-scale integrating projectCoordinator
20132 Milano
Italy
See on map
Participants (28)
Participation ended
69002 LYON
See on map
75654 Paris
See on map
63225 Langen
See on map
30625 Hannover
See on map
1015 Lausanne
See on map
WC1E 6BT LONDON
See on map
Participation ended
10117 Berlin
See on map
80539 MUNCHEN
See on map
Participation ended
13125 Berlin
See on map
41121 Modena
See on map
2333 ZA Leiden
See on map
3015 GD Rotterdam
See on map
22100 LUND
See on map
69120 Heidelberg
See on map
Participation ended
9052 ZWIJNAARDE - GENT
See on map
8092 Zuerich
See on map
TW20 0EX Egham
See on map
55743 IDAR OBERSTEIN
See on map
91002 Evry
See on map
78467 Konstanz
See on map
20091 BRESSO MI
See on map
Participation ended
69002 LYON
See on map
69002 Lyon
See on map
28040 MADRID
See on map
60596 Frankfurt
See on map
1050 Bruxelles / Brussel
See on map
79106 Freiburg
See on map
20132 Milano
See on map